.

The prevalence of mild cognitive impairment in T2DM patients: a systematic review and meta‑analysis

by · December 6, 2021

Type 2 diabetes mellitus (T2DM) can be a high risk for Mild Cognitive Impairment (MCI). Early detection of cognitive function can help delay cognitive decline. Hence, Yue You and colleagues conducted a study published in Acta Diabetologica under the title “The prevalence of mild cognitive impairment in type 2 diabetes mellitus patients: a systematic review and meta‑analysis”. The summary of this study is given below:

Objective:

To investigate the prevalence of MCI in T2DM patients

Method:

A literature search was conducted for observational studies on databases such as Medline (Pubmed), Embase, and Web of Science until 1st June 2020. Articles were shortlisted by two independent reviewers followed by a metanalysis to investigate the prevalence of MCI in T2DM patients.

Findings:

Investigators conclude that MCI is more prevalent in T2DM patients worldwide. MCI is one of the risk factors for developing Alzheimer’s disease. The prevalence of MCI is higher in males whereas comorbid MCI inT2DM is more prevalent in females. There is a high risk of cognitive impairment with a high level of blood glucose. Hence, delay in diagnosis can lead to chronic complications and there should be an appropriate treatment strategy with pre-diabetes patients.

Image Credit : Background photo created by kjpargeter – www.freepik.com

Afshin Sayyed

Afshin Sayyed joined Zandra Healthcare as an Editor in 2020. She has completed her Bachelor's in Nutrition and Dietetics from SNDT (Shreemati Nathibai Damodar Thackersey Women's) University. She has completed her PG Diploma in Clinical Nutrition and Dietetics from Mumbai University. She is a Certified Diabetes Educator and Content Writer. She has experience in Community Nutrition and other fieldwork with NGO's as well as corporate sectors.

You may also like...

DIABETES SECTION SPONSORDIGEST SPONSOR